Patent · US Active

Antibodies and methods for making and using them

US8465741B2 · kind B2 · utility

10Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2007
Grant dateJun 18, 2013
Priority date—
Expiry dateSep 20, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/734
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies, including chimeric human antibodies, recombinant antibodies, synthetic antibodies, and the nucleic acids encoding them, and methods for making and using these immunoglobulins. The invention provides recombinant and synthetic polypeptide and nucleic acid embodiments of these polypeptides and/or antibodies. The invention also provides polypeptides comprising, or consisting of, consensus human framework regions, or “Independently Consensused Frameworks (ICFs)”, nucleic acids encoding them, and libraries and kits comprising these ICFs and/or antibodies of the invention, individually and in combinatorial libraries and combinations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.